Status:
ACTIVE_NOT_RECRUITING
Detection and Classification of Cardiac Rhythm and Atrial Fibrillation Using a Finger-worn Ring
Lead Sponsor:
Everbeat
Conditions:
Atrial Fibrillation (AF)
Arrhythmias Cardiac
Eligibility:
All Genders
18+ years
Brief Summary
Everbeat is a finger-worn ring that has a built-in electrocardiogram (ECG). In this study the investigators ensure that the ECG as read by the everbeat correctly classifies heart rhythms and detects a...
Detailed Description
In this study the participant will obtain a simultaneous electrocardiogram from both the everbeat ring system and a clinical-grade diagnostic ECG machine for correlation and analysis.
Eligibility Criteria
Inclusion
- 18 years of age or older
Exclusion
- Presence of pacemaker or defibrillator
- Inability to wear a ring in size range available
Key Trial Info
Start Date :
September 17 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2025
Estimated Enrollment :
232 Patients enrolled
Trial Details
Trial ID
NCT06892938
Start Date
September 17 2024
End Date
April 1 2025
Last Update
March 27 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
XIMED
La Jolla, California, United States, 92037
2
Our Lady of Lake Hospital
Baton Rouge, Louisiana, United States, 70808
3
Allegheny General Hospital
Pittsburgh, Pennsylvania, United States, 15232